Imiquimod is an immune response modifier and Toll-like receptor 7 agonist belonging to the imidazoquinoline class, primarily prescribed as a topical treatment for conditions including actinic keratosis,… Read more
![Chemical structure of 1-(4-Aminobutyl)-2-ethyl-1H-imidazo[4,5-c]quinolin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F313350-30-0-1-4-Aminobutyl-2-ethyl-1H-imidazo45-cquinolin-4-amine.png&w=3840&q=75)
![Chemical structure of 1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F99010-99-8-1-Isobutyl-1H-imidazo45-cquinolin-4-ol.png&w=3840&q=75)
![Chemical structure of 1-Isobutyl-4-methoxy-1H-imidazo[4,5-c]quinoline](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F99010-98-7-1-Isobutyl-4-methoxy-1H-imidazo45-cquinoline.png&w=3840&q=75)
![Chemical structure of 1-Isobutyl-N-methyl-1H-imidazo[4,5-c]quinolin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F853793-02-9-1-Isobutyl-N-methyl-1H-imidazo45-cquinolin-4-amine.png&w=3840&q=75)







![Chemical structure of Imiquimod Related Compound A (1-Isobutyl-1H-imidazo[4,5-c]quinoline) (1338324)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F99010-24-9-Imiquimod-Related-Compound-A-1-Isobutyl-1H-imidazo45-cquinoline-1338324.png&w=3840&q=75)
![Chemical structure of Imiquimod Related Compound B (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide) (1338335)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F99010-63-6-Imiquimod-Related-Compound-B-1-Isobutyl-1H-imidazo45-cquinoline-5-oxide-1338335.png&w=3840&q=75)
![Chemical structure of Imiquimod Related Compound C (4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline) (1338346)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F99010-64-7-Imiquimod-Related-Compound-C-4-Chloro-1-isobutyl-1H-imidazo45-cquinoline-1338346.png&w=3840&q=75)
![Chemical structure of Imiquimod Related Compound D (1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine) (1338357)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F853792-81-1-Imiquimod-Related-Compound-D-1-Propyl-1H-imidazo45-cquinolin-4-amine-1338357.png&w=3840&q=75)





Imiquimod is an immune response modifier and Toll-like receptor 7 agonist belonging to the imidazoquinoline class, primarily prescribed as a topical treatment for conditions including actinic keratosis, superficial basal cell carcinoma, and genital warts. This category provides essential reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope labelled compounds. Laboratories require these materials for critical analytical tasks, including the development and validation of analytical methods to ensure regulatory compliance. Accurate impurity profiling, which involves characterizing structural analogs and degradation products formed through processes such as hydrolysis or oxidation, is vital for assessing drug stability and safety during quality control. Furthermore, stable isotope labelled compounds serve as internal standards for mass spectrometry, enabling precise measurement of the drug and its metabolites in complex matrices during pharmaceutical research and stability studies.